SynCardia Systems, Inc. 2014 Engineering Scholarship For Women Awarded To University of Arizona Junior Justine Bacchus

TUCSON, Ariz., Nov. 12, 2014 /PRNewswire/ -- SynCardia Systems, Inc., has awarded its Anna Salazar Memorial Engineering Scholarship to University of Arizona junior Justine Bacchus, who is pursuing her undergraduate degree in biomedical engineering.

Michael P. Garippa, SynCardia CEO and President, awards the Anna Salazar Memorial Scholarship to Justine Bacchus, who is a biomedical engineering junior at the University of Arizona. The late Anna Salazar was a senior quality engineer at SynCardia.

SynCardia implemented the scholarship to support University of Arizona female engineering students working to make a significant contribution to society. It honors the late Anna Salazar, who joined SynCardia in 2012 and made a lasting mark on the company as a senior quality engineer.

Review SynCardia scholarship details and application instructions

“We hope that the scholarship will allow outstanding women engineering students to reach their academic and professional goals and, like Anna, contribute to society in astounding ways,” says SynCardia CEO and President Michael P. Garippa.

Justine Bacchus says she will use the $5,000 award to pay for tuition and books.

“I knew I wanted to do something medical,” she says, “but I didn’t want to be a doctor.”

Bacchus believes gaining engineering knowledge will help her in her goal to become a genetic counselor.

“I want to help patients directly,” she says. “The counseling part is attractive. I like teaching people about what their genes mean to their health.”

Information on the next round of applications for the scholarship is available by sending an email to scholarship@syncardia.com or going to the UA’s Scholarship Universe website.

For additional information, please visit: http://www.syncardia.com/

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. in Tucson, Arizona is the privately-held owner and manufacturer of the world’s first and only FDA, Health Canada and CE approved Total Artificial Heart.

Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end-stage biventricular heart failure in which both ventricles can no longer pump enough blood for a person to survive.

More than 1,350 implants of the SynCardia Total Artificial Heart accounts for over 400 patient years of life on the device. Since January 2010 more than 500 SynCardia Hearts have been implanted.

SynCardia Systems also manufactures the Freedom® portable driver, which powers the SynCardia Heart while allowing clinically stable patients to leave the hospital to live at home and in their communities. The wearable Freedom driver has been used by over 190 patients, accounting for over 110 years of support.

Photo - http://photos.prnewswire.com/prnh/20141111/157949

SOURCE SynCardia Systems, Inc.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC